Lack of Association of BRCA1 and BRCA2 Variants with Breast Cancer in an Ethnic Population of Saudi Arabia, an Emerging High-Risk Area

  • Hasan, Tarique Noorul (Molecular Cancer Biology Research Lab (MCBRL), Depatment of Food Science and Nutrition, King Saud University) ;
  • Shafi, Gowhar (Molecular Cancer Biology Research Lab (MCBRL), Depatment of Food Science and Nutrition, King Saud University) ;
  • Syed, Naveed Ahmed (Molecular Cancer Biology Research Lab (MCBRL), Depatment of Food Science and Nutrition, King Saud University) ;
  • Alsaif, Mohammed Abdullah (Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University) ;
  • Alsaif, Abdulaziz Abdullah (Department of Surgery, College of Medicine, King Saud University) ;
  • Alshatwi, Ali Abdullah (Molecular Cancer Biology Research Lab (MCBRL), Depatment of Food Science and Nutrition, King Saud University)
  • Published : 2013.10.30


Incidence of breast cancer shows geographical variation, even within areas of ethnic homogeneity. Saudi Arabia has witnessed an increase in occurrence of breast cancer in its unexplored ethnic populations over the past few years. We aimed at determining whether any association exists between single nucleotide polymorphisms in breast cancer associated gene 1 (BRCA1) and breast cancer associated gene 2 (BRCA2) and the risk of breast cancer. TaqMan based Real Time Polymerase chain reaction genotyping assays were used to determine the frequency of single nucleotide polymorphisms in BRCA1 (rs799917) and BRCA2 (rs144848) in a group of 100 breast cancer patients and unaffected age matched controls of Saudi Arabian origin. The present data revealed that neither BRCA1 nor the BRCA2 studied variant show any significant association with the disease. This study failed to find any role of the concerned variants in breast cancer either as risk or as prognostic factors. The small number of patients registered was one of the limitations of this study. In summary, comparison of mutation profile with other ethnic populations and regions reflected both differences and similarities indicating co-exposure to a unique set of risk factors. The differences could be due to exposure to particular environmental carcinogens; different lifestyle, reproductive pattern; dietary or cultural practices of Saudi Arabian women that need further investigations.


BRCA1;BRCA2;single nucleotide polymorphism;breast cancer;Saudi Arabia


  1. Elkum N, Dermime S, Tulbah A (2007). Age 40 and younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer, 5, 222.
  2. Agalliu I, Kwon EM, Salinas CA, et al (2010). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control, 21, 289-300.
  3. Alshatwi AA, Shaf G, Hasan TN, et al (2011). Single nucleotide polymorphisms in the p21 and bcl2 cancer susceptibility genes and breast cancer risk in Saudi Arabia. Asian Pac J Cancer Prev, 12, 2607-10.
  4. Bin Amer SM, Maqbool Z, Nirmal MS, et al (2008). Gene expression profiling in women with breast cancer in Saudi population. Saudi Med J, 29, 507-13.
  5. Cox DG, Kraft P, Hankinson SE, Hunter DJ (2005). Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res, 7, 171-5.
  6. Cox DG, Hankinson SE, Hunter DJ (2005). No association between BRCA2 N372H and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 1353-4.
  7. Ezzat AA, Ibrahim EM, Raja MA, (1999). Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol, 16, 95-103.
  8. Ford D, Easton DF, Stratton M, et al (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet, 62, 676-89.
  9. Gayther SA, Warren W, Mazoyer S, et al (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet, 11, 428-33.
  10. Huo X, Lu C, Huang X, et al (2009). Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J Cancer Res Clin Oncol, 135, 1569-75.
  11. Jiao J, Zheng T, Lan Q, et al (2012). Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma. Eur J Cancer Prev, 21, 580-4.
  12. Palli D, Falchetti M, Masala G, et al (2007). Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy. BMC Cancer, 3, 170.
  13. Kruglyak L (1999). Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet, 22, 139-44.
  14. Ma H, Jin G, Hu Z, et al (2006). Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer, 119, 2173-8.
  15. Nicoloso MS, Sun H, Spizzo R, et al (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res, 70, 2789-98.
  16. Pharoah PD, Antoniou A, Bobrow M, et al (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet, 31, 33-6.
  17. Reedy M, Gallion H, Fowler JM, Kryscio R, Smith SA (2002). Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol, 85, 255-9.
  18. Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS (2006). Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood, 108, 638-44.
  19. Sehl ME, Langer LR, Papp JC, et al (2009). Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res, 15, 2192-203.
  20. Song CG, Hu Z, Wu J, et al (2006). The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol, 132, 617-26.
  21. Spurdle AB, Hopper JL, Chen X, et al (2002). The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev, 11, 413-6.
  22. Venter JC, Adams MD, Myers EW, et al (2001). The sequence of the human genome. Science, 291, 1304-51.
  23. Wu X, Zhao H, Suk R, Christiani DC (2004). Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-23.

Cited by

  1. No Association between BRCA1 Immunohistochemical Expression and Tumor Grade, Stage or Overall Survival in Platinum-Treated Epithelial Ovarian Cancer Patients vol.15, pp.10, 2014,
  2. BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis vol.16, pp.3, 2015,
  3. Individualized medicine enabled by genomics in Saudi Arabia vol.8, pp.S1, 2015,
  4. BRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer vol.94, pp.42, 2015,
  5. Identification and frequency of the rs12516 and rs8176318 BRCA1 gene polymorphisms among different populations vol.11, pp.4, 2016,
  6. Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan vol.18, pp.1, 2018,
  7. Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women vol.21, pp.2, 2018,